Search results
Results from the WOW.Com Content Network
In 2002, Alnylam was founded by scientists Phillip Sharp, Paul Schimmel, David Bartel, Thomas Tuschl, and Phillip Zamore, and by investors Christoph Westphal and John Kennedy Clarke; John Maraganore was the founding CEO. [5] [7] [8] The company was named after Alnilam, a star in Orion's belt. The spelling was modified to make it unique. [9]
In this article we will take a look at whether hedge funds think Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a good investment right now. We check hedge fund and billionaire investor sentiment ...
Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners. [1] [2] [3] She focuses on investing in healthcare companies and early-stage biotech start-ups.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Yvonne Greenstreet is the daughter of a Ghanaian mother, Miranda Greenstreet, and a white Englishman. The pair met in the 1950s as students at the London School of Economics.
EVP, Chief Legal Officer of Alnylam Pharmaceuticals Inc (30-Year Financial, Insider Trades) Laurie Keating (insider trades) sold 9,027 shares of ALNY on 01/13/2021 at an average price of $169.9 a ...
Corporate titles or business titles are given to company and organization officials to show what job function, and seniority, a person has within an organisation. [1] The most senior roles, marked by signing authority, are often referred to as "C-level", "C-suite" or "CxO" positions because many of them start with the word "chief". [2]